The partnership will support development of a range of biotechnology solutions in areas of human therapeutics, tissue fabrication and...
Engineering rigor and invention are our core principles, but we start with a focus on biology.
Whether we are modeling or engineering cells and tissues, analyzing large datasets, developing new imaging technologies, or synthesizing novel biomaterials, the problem statement always starts with the biology underlying the system, therapy, or disease process.
Our co-location within the highly-ranked UVA School of Medicine and Health System uniquely positions us to influence the future of healthcare. Our culture values and rewards collaboration, initiative, and the translation of basic advances to achieve clinical and real world impact. In all that we do, we value and strive for diversity and inclusion.
The University is one of a handful schools nationwide participating in the Beckman Scholars program, largely because of its commitment...
Some women who store fat in their bellies and hips may be at increased risk for Type 2 diabetes, due to a natural variation of the...
Technology developed in the Papin Lab marks the first new technology in the plate reader market in decades.
Professor of Biomedical Engineering and Orthopaedic Surgery, Mary Muilenburg Stamp Professor of Orthopaedic Research, Director of Basic and Translational Research in Orthopaedic Surgery, Fellow of AIMBE
- Materials and Advanced Manufacturing for Biological Applications
- Biomechanics/Injury Biomechanics or Biomechanics and Mechanobiology
More About Our Department
Biomedical Engineering Informational Brochure
Biomedical Engineering Research Newsletter
$ 12 M
annual research expenditures 2016-2017
$ 480 K
research funding per faculty member from external sources 2016-2017
of BME Ph.D. candidates are fully funded
$ 25 M
UVA Coulter Translational Research Partnership endowment